Steven Cohen Veracyte, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Veracyte, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 566,634 shares of VCYT stock, worth $21.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
566,634
Previous 566,634
-0.0%
Holding current value
$21.2 Million
Previous $12.3 Million
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding VCYT
# of Institutions
270Shares Held
78.7MCall Options Held
42.3KPut Options Held
18.2K-
Black Rock Inc. New York, NY7.79MShares$291 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.5MShares$280 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA6.88MShares$257 Million0.03% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$184 Million1.59% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.17MShares$118 Million0.44% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.67B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...